z-logo
open-access-imgOpen Access
Management of anorexia prevents skeletal muscle wasting during cisplatin‐based chemotherapy for thoracic malignancies
Author(s) -
Miyawaki Eriko,
Naito Tateaki,
Nakashima Kazuhisa,
Miyawaki Taichi,
Mamesaya Nobuaki,
Kawamura Takahisa,
Kobayashi Haruki,
Omori Shota,
Wakuda Kazushige,
Ono Akira,
Kenmotsu Hirotsugu,
Murakami Haruyasu,
Mori Keita,
Takahashi Toshiaki
Publication year - 2020
Publication title -
jcsm clinical reports
Language(s) - English
Resource type - Journals
ISSN - 2521-3555
DOI - 10.1002/crt2.8
Subject(s) - anorexia , medicine , vomiting , nausea , chemotherapy , wasting , skeletal muscle , antiemetic , gastroenterology , surgery , oncology
Background Cancer‐associated skeletal muscle loss often occurs in patients with advanced lung cancer who are receiving chemotherapy. This study aimed to elucidate the impact of chemotherapy‐induced nausea and vomiting (CINV) or anorexia on muscle wasting. Methods In this post‐hoc analysis of a phase II clinical trial of antiemetic agents, chemotherapy‐naïve Japanese patients with thoracic malignancies were prospectively recruited between May and October 2015. Total control of CINV was defined as the absence of nausea and vomiting without rescue therapy 0–120 h after each course of chemotherapy. Non‐anorexia was defined as having no anorexia or having an anorexia grade no higher than ‘1’ during the 3 month period following chemotherapy initiation. Skeletal muscle mass was measured by computed tomography, and lumbar skeletal muscle index (LSMI) was calculated. Results Among 29 patients, CINV was totally controlled in 7 (24%) and grade 2 or 3 anorexia was observed in 10 (34%). The LSMI significantly decreased across the entire cohort (mean ± standard error of the mean: −3.1 ± 0.6 cm 2 /m 2 , P  < 0.01); this reduction was similar among patients with and without total control of CINV (−4.1 ± 1.3 vs. −2.8 ± 0.7 cm 2 /m 2 , P  = 0.38). Patients with anorexia experienced a larger decrease in LSMI than did those without anorexia during the study period (−5.4 ± 0.9 vs. −1.9 ± 0.7 cm 2 /m 2 , P  < 0.01). Conclusions Significant skeletal muscle mass depletion was observed despite well‐controlled CINV. Continuous oral food intake may be required throughout the course of cisplatin‐based chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here